These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10471075)

  • 21. A novel PCR-RFLP assay for the detection of the single nucleotide polymorphism at position +1440 in the human CXCR2 gene.
    Viana AC; Kim YJ; Cirelli JA; Orrico SR; Curtis KC; Cano VS; Valentini SR; Scarel-Caminaga RM
    Biochem Genet; 2007 Oct; 45(9-10):737-41. PubMed ID: 17939034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
    Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
    Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.
    Fukuen S; Fukuda T; Maune H; Ikenaga Y; Yamamoto I; Inaba T; Azuma J
    Pharmacogenetics; 2002 Jun; 12(4):331-4. PubMed ID: 12042671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism.
    Brüning T; Abel J; Koch B; Lorenzen K; Harth V; Donat S; Sachinidis A; Vetter H; Bolt HM; Ko Y
    Arch Toxicol; 1999 Nov; 73(8-9):427-30. PubMed ID: 10650913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid communication: polymerase chain reaction-restriction fragment length polymorphism in the bovine growth hormone gene.
    Unanian MM; DeNise SK; Zhang HM; Ax RL
    J Anim Sci; 1994 Aug; 72(8):2203. PubMed ID: 7982852
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic polymorphism in cytochrome P450 1B1 in a Spanish population.
    Pérez-Cadahía B; Valdiglesias V; Pásaro E; Méndez J; Laffon B
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):70-2. PubMed ID: 17577319
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of a new non-functional CYP2C18 allele in Japanese: substitution of T204 to A in exon2 generates a premature stop codon.
    Komai K; Sumida K; Kaneko H; Nakatsuka I
    Pharmacogenetics; 1996 Feb; 6(1):117-9. PubMed ID: 8845859
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid communication: length polymorphism in the swine alpha-actin locus.
    Schmitz CB; Rothschild MF; Tuggle CK
    J Anim Sci; 1994 Jul; 72(7):1910. PubMed ID: 7928773
    [No Abstract]   [Full Text] [Related]  

  • 29. Genotyping human cytochrome: P450 1B1 variants.
    Sutter CH; Qian Z; Hong YP; Mammen JS; Strickland PT; Sutter TR
    Methods Enzymol; 2002; 357():53-8. PubMed ID: 12424897
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic analysis of the cytochrome P-45OIIC18 (CYP2C18) gene and a novel member of the CYP2C subfamily.
    Tsuneoka Y; Matsuo Y; Okuyama E; Watanabe Y; Ichikawa Y
    FEBS Lett; 1996 Apr; 384(3):281-4. PubMed ID: 8617372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A MnlI restriction site polymorphism in the interleukin-10 gene promoter.
    Zheng F; Gabriel C; Batavia A; Zhou X; Ye SQ
    Biochem Genet; 2001 Oct; 39(9-10):351-6. PubMed ID: 11758730
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.
    Kawajiri K; Nakachi K; Imai K; Yoshii A; Shinoda N; Watanabe J
    FEBS Lett; 1990 Apr; 263(1):131-3. PubMed ID: 1691986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BslI PCR/RFLP marker in the canine connexin 40 (CX40 or GJA5) gene.
    Brouillette JA; Stafford A; Hammer TA; Venta PJ
    Anim Genet; 1999 Jun; 30(3):229-30. PubMed ID: 10442994
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of allelic variants of the human CYP1A1 gene.
    Kawajiri K; Watanabe J; Hayashi S
    Methods Enzymol; 1996; 272():226-32. PubMed ID: 8791781
    [No Abstract]   [Full Text] [Related]  

  • 35. Restriction endonuclease-catalyzed cleavage of DNA stimulates subsequent polymerase chain reaction and enables discrimination between normal and mutant K-RAS alleles.
    Botezatu IV; Serdyuk OI; Potapova GI; Shelepov VP; Likhtenshtein AV
    Dokl Biochem Biophys; 2003; 393():331-3. PubMed ID: 14870613
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancer.
    Okada T; Kawashima K; Fukushi S; Minakuchi T; Nishimura S
    Pharmacogenetics; 1994 Dec; 4(6):333-40. PubMed ID: 7704039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequencing: not always the "gold standard".
    van der Heiden IP; van der Werf M; Lindemans J; van Schaik RH
    Clin Chem; 2004 Jan; 50(1):248-9. PubMed ID: 14709666
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer.
    Rebbeck TR; Rosvold EA; Duggan DJ; Zhang J; Buetow KH
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):511-4. PubMed ID: 8000303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 2-point linked mutations in the 5'-flanking region of human CYP2C18.
    Iwahashi K; Okuyama E; Furukawa A; Nakamura K; Miyatake R; Matsuo Y; Ichikawa Y
    Clin Chim Acta; 1996 Aug; 252(2):197-9. PubMed ID: 8853566
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of restriction fragment length polymorphism of cytochrome P450 3A43 gene and evaluation of the incidence of CYP3A43*1B allele in europeoid residents of West Siberia.
    Shchepotina EG; Nikishina MV; Vavilin VA; Lyakhovich VV
    Bull Exp Biol Med; 2005 Dec; 140(6):726-8. PubMed ID: 16848237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.